BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31623932)

  • 1. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.
    Lo JA; Fisher DE
    Science; 2014 Nov; 346(6212):945-9. PubMed ID: 25414302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution.
    Shain AH; Joseph NM; Yu R; Benhamida J; Liu S; Prow T; Ruben B; North J; Pincus L; Yeh I; Judson R; Bastian BC
    Cancer Cell; 2018 Jul; 34(1):45-55.e4. PubMed ID: 29990500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.
    McKinney AJ; Holmen SL
    Chin J Cancer; 2011 Mar; 30(3):153-62. PubMed ID: 21352692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.
    Motwani J; Eccles MR
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From fish bowl to bedside: The power of zebrafish to unravel melanoma pathogenesis and discover new therapeutics.
    van Rooijen E; Fazio M; Zon LI
    Pigment Cell Melanoma Res; 2017 Jul; 30(4):402-412. PubMed ID: 28379616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic landscapes of individual melanocytes from human skin.
    Tang J; Fewings E; Chang D; Zeng H; Liu S; Jorapur A; Belote RL; McNeal AS; Tan TM; Yeh I; Arron ST; Judson-Torres RL; Bastian BC; Shain AH
    Nature; 2020 Oct; 586(7830):600-605. PubMed ID: 33029006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape.
    Vanni I; Tanda ET; Spagnolo F; Andreotti V; Bruno W; Ghiorzo P
    Front Mol Biosci; 2020; 7():113. PubMed ID: 32695793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human melanocyte development and melanoma dedifferentiation at single-cell resolution.
    Belote RL; Le D; Maynard A; Lang UE; Sinclair A; Lohman BK; Planells-Palop V; Baskin L; Tward AD; Darmanis S; Judson-Torres RL
    Nat Cell Biol; 2021 Sep; 23(9):1035-1047. PubMed ID: 34475532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant features of minipig melanomas prior to spontaneous regression.
    Débare H; Blanc F; Piton G; Leplat JJ; Vincent-Naulleau S; Rivière J; Vilotte M; Marthey S; Lecardonnel J; Coville JL; Estellé J; Rau A; Bourneuf E; Egidy G
    Sci Rep; 2024 Apr; 14(1):9240. PubMed ID: 38649394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
    Saito R; Sawada Y; Nakamura M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE; Bosenberg M
    Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
    Webster JD; Pham TH; Wu X; Hughes NW; Li Z; Totpal K; Lee HJ; Calses PC; Chaurushiya MS; Stawiski EW; Modrusan Z; Chang MT; Tran C; Lee WP; Chalasani S; Hung J; Sharma N; Chan S; Hotzel K; Talevich E; Shain A; Xu M; Lill J; Dixit VM; Bastian BC; Dey A
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):269-279. PubMed ID: 30156010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in malignant melanoma: genetic insights from mouse and man.
    Kabbarah O; Chin L
    Front Biosci; 2006 Jan; 11():928-42. PubMed ID: 16146783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolution of Melanoma - Moving beyond Binary Models of Genetic Progression.
    Zeng H; Judson-Torres RL; Shain AH
    J Invest Dermatol; 2020 Feb; 140(2):291-297. PubMed ID: 31623932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making a melanoma: Molecular and cellular changes underlying melanoma initiation.
    Darp R; Ceol C
    Pigment Cell Melanoma Res; 2021 Mar; 34(2):280-287. PubMed ID: 33283422
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.